An updated guideline on pharmacotherapy of obesity management in adults includes six new and seven revised recommendations, ...

Patients with psoriasis have significantly more difficulty sleeping, particularly in new environments, than matched ...

Here are two beaten-down stocks that long-term investors might want to consider buying on the dip and holding for several ...

GSK (NYSE:GSK) (LON:GSK) said on Monday that the U.S. Food and Drug Administration has accepted its priority review ...

New York hospitals that get discounted drugs through a controversial federal program are gearing up for a new pilot that they ...

The recent portfolio rebalance increased FDL's risk and volatility, with 55% concentration in its top 10 holdings. Read why I ...

Here are five oral obesity candidates that, according to Mizuho’s Graig Suvannavejh, could change the weight loss game.

GSK (NYSE:GSK) announced Monday that the U.S. Food and Drug Administration has accepted its priority review application for ...

Websites claiming to sell pharmaceuticals without need of prescriptions are popping up in the thousands. They are part of a ...

Pfizer ( PFE) shares gained on Tuesday after the New York-based pharma giant reported better-than-expected financials for Q2 2025 and increased its full-year earnings outlook, citing, among other ...

Chasing a 100 times return might not be a great idea. But there are lessons to be taken from past winners of this magnitude.

According to the Centers for Disease Control and Prevention, the strain is now the third most common COVID-19 variant in the United States.